UK Approves Pfizer BioNTech Vaccine, PFE Up 3.91% or $1.54 Pre-market

(CNN)Drugmaker Pfizer and its German partner BioNTech have been granted temporary authorization for emergency use of their Covid-19 vaccine in the UK, the companies announced.

This marks the first time that citizens outside of the worldwide clinical trials will have the opportunity to be immunized against Covid-19, according to BioNTech CEO Ugur Sahin.

The vaccine will be made available across the UK starting next week, a spokesperson from the Department of Health and Social Care said in a statement.

click link for full CNN report
source: CNN.com